Crowdonomics
All companies

Healthtech Solutions, Inc./UT

Operating

Healthcare · Salt Lake City, UT

Latest valuation
—
No round has disclosed a priced valuation or cap.
Total raised
$3,377,720
Crowd $0 · Private $3.4M · 3 rounds since 2020
Latest share price
$50.00
Reg A Offering (2021) offering price

Financials

FY2019–FY2022 · from SEC filings · hover any figure for its source
$0
−$549K
2019
$0
−$732K
2020
$0
−$9.1M
2021
$1.7M
−$3.0M
2022
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2019 audited
FY2020 audited
FY2021 audited
FY2022 audited
Income statement
Revenue
$0
$0
$0
$1,687,691
Cost of goods sold
$0
—
$0
$123,857
Gross margin
—
—
—
93%
Net income
-$548,668
-$732,208
-$9,109,217
-$3,043,585
Taxes paid
—
$0
$0
$0
Balance sheet
Cash
$0
$128,996
$7,105
$97,588
Accounts receivable
$0
—
$0
$1,238,509
Total assets
$170,569
$164,922
$423,102
$2,752,387
Long-term debt
$643,558
—
—
—
Total liabilities
$36,400
$727,519
$1,070,665
$5,827,256
Other
Headcount
2
—
—
—

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Cap table

Share counts as of Mar 8, 2021
Series A Preferred Stock · 44.7%common stock · 55.3%
ClassOutstandingVotes / shareConvertsAs convertedLast price
Series A Preferred Stockpreferred156,937—50 × common stock44.7%—
common stock9,701,269——55.3%—
Total9,858,20617,548,119 as converted100%

Principal holders% as the filing states it, Sep 4, 2020

  • of Class Robert Brantl6,465,442 shares66.6%of company
  • Everyone else (not named in filings)33.4%

From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. “As converted” counts each class in the shares it converts into. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.

Fundraising history

Raised $2.6MInvestors 30
Raised $0 / $75M
Raised $781.5KInvestors 5

Team

5 people
David Rubin
CEO
Manuel Iglesias
President (COO)
Richard F. Parker
Chief Research Officer (Medi-Scan)
Robert Brantl
Secretary
Denis Kleinfeld
Director

Names and titles as disclosed on SEC Form 1-A. Bios and photos come from the platform campaign page and may be out of date.

  • Form 10-KJun 28, 20230001262463-23-000045
    EDGAR
  • Form 10-QNov 23, 20220001262463-22-000147
    EDGAR
  • Form 10-QAug 19, 20220001262463-22-000117
    EDGAR
  • Form 10-QMay 20, 20220001262463-22-000087
    EDGAR
  • Form 10-KApr 15, 20220001262463-22-000054
    EDGAR
  • Form 10-QNov 22, 20210001262463-21-000586
    EDGAR
  • Form 10-Q/AAug 25, 20210001262463-21-000414
    EDGAR
  • Form 10-QAug 23, 20210001262463-21-000407
    EDGAR
Source: SEC EDGARCIK 0001307624UTShare price $50.00Last synced Aug 16, 2026

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.